Replies to post #94169 on Cytodyn Inc (CYDY)

[$5.95akadawson-m]

My information falls into the category that usually says: I have enough information that to be dangerous, not helpful.

Given that, Itolizumab is a treatment for psoriasis and as an associated MAB, confers benefits to other auto-immune diseases.

Itolizumab is NOT for an HIV treatment but its side effects are minimal yet no one has said at this point, what is more influential in Covid, CD6 or Rantes?

I'm sticking with Leronlimab.

How much more analysis, trials would have to be initiated to find out the differences between these two mabs?

Yet, most of the trials are in for Leronlimab...



From Pub-Med:

Itolizumab in Psoriasis.
Srivastava A.
Indian J Dermatol. 2017 Jul-Aug;62(4):418-421. doi: 10.4103/ijd.IJD_467_16.